Spinout companies

Spinouts banner

Our spinout portfolio is valued at over £200m, and our companies have attracted over £100m investment since 2010.

We welcome approaches from senior managers looking for executive or non-executive positions, and from investors who want to keep in touch with existing or emerging spinouts.

For more details on the spinout portfolio, or to find out about the next fundraising or investment event we will be attending, please contact David Coleman.


Spinout companies include

Smart Antenna Technologies Ltd

Smart Antenna

SAT has designed, developed and patented a pioneering smart antenna technology which provides an efficient and low cost antenna solution for the mobile device and infrastructure market. Target markets include smartphone, tablet, laptop but the technology can also be applied to expanding markets including SmartTV, Connected Car, Small Cell and IoT/M2M.

visit website

Irresistible Materials Ltd

Irresistable Materials

Current polymer technologies cannot be used to make the ever-smaller features required in next generation of semi-conductors. Irresistible Materials has developed unique and novel forms of fullerine – hollow carbon molecules used in spin-on carbon materials that are printed to a depth of just 13nm.

visit website

Cytox Ltd


Cytox has developed a unique scientific and proprietary technology platform that is helping to elucidate the biology behind dementia risk. Our focus is on development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

visit website

Linear Diagnostics Ltd

Linear Diagnostics

Linear Diagnostics has developed a platform technology that uses linear dichroism to test for bacteria and antibiotic resistance. The advantages of the technology include portability (the device is hand-held), speed (it only takes 2 minutes to get a result) and the ability to check for multiple targets and types of targets in the same test.

visit website

Abingdon Health Ltd


Abingdon Health is a UK-based diagnostics group focused on developing, manufacturing and commercialising immunoassay tests and reader systems.

visit website

Alta Bioscience Ltd


Alta Bioscience provides analytical laboratory services in addition to custom syntheses of peptides, DNA oligos and both polyclonal and monoclonal antibodies. The testing services include amino acid analysis, protein sequencing, steroid analysis and other mass spec analytical techniques.

visit website

PsiOxus Ltd


PsiOxus discovers and develops innovative immunotherapies for the treatment of solid tumors. Our products utilize enadenotucirev, our proprietary first generation oncolytic virus and our proprietary platform technology for next generation oncolytic viruses, Tumor-Specific Immuno-Gene Therapy (T-SIGn).

visit website


profile-psiCelentyx offers bespoke assay services in human immunology, immuno-onology, fibrosis and neuroinflammation, supporting candidate selection, medium-throughput screening, differentiation, mechanism of action, target discovery and proof of concept studies.

Our technologies include multi-colour flow cytometry, multiplex cytokine analysis, quantitative immunohistochemistry, immuno-fluorescence microscopy, quantitative image analysis, target deconvolution, qPCR, RNAseq, and electrophysiology.

visit website